The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption

Allergy. 2021 Jun;76(6):1900-1902. doi: 10.1111/all.14707. Epub 2020 Dec 27.

Authors

Alba Angelina¹, Mar Martín-Fontecha², Beate Rückert³, Paulina Wawrzyniak³, Mario Pérez-Diego¹, Jacobo López-Abente¹, Mübeccel Akdis³, Cezmi A Akdis³, Oscar Palomares¹

Affiliations

¹ Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
² Department of Organic Chemistry, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
³ Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.

PMID: 33319366
DOI: 10.1111/all.14707

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Benzoxazines / adverse effects
Cannabinoids*
Humans
Morpholines
Naphthalenes
Receptor, Cannabinoid, CB1
Rhinovirus*

Substances

Benzoxazines
Cannabinoids
Morpholines
Naphthalenes
Receptor, Cannabinoid, CB1
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone